Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

NCT05937776 · clinicaltrials.gov ↗

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

OTHER: Fludeoxyglucose F-18
OTHER: Gadoterate Meglumine
PROCEDURE: Contrast-enhanced Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]